Investors might want to bet on Corcept Therapeutics (CORT), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

Investors might want to bet on Corcept Therapeutics (CORT), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...

Canaccord Genuity maintained its Buy rating and $78.00 price target for NASDAQ:CORT, Corcept Therapeutics (NASDAQ:CORT). The firm highlighted the company's solid performance as the third quarter comes ...

Canaccord Genuity maintained its Buy rating and $78.00 price target for NASDAQ:CORT, Corcept Therapeutics (NASDAQ:CORT). The firm highlighted the company's solid performance as the third quarter ...

buy showroom samples, or invest in heirloom quality," she says. Trendy furniture pieces are often reproductions of more ...

Inflation trends have been affecting the prices of all kinds of home items, from groceries to furniture. So, what if you need to stock up on furniture with a smaller budget? This might seem ...

Corcept (CORT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). Corcept, Amneal, Bioventus, Foghorn and Akebia have ...

In a report released today, Joon Lee from Truist Financial assigned a Buy rating to Corcept Therapeutics (CORT – Research Report). The company’s shares closed yesterday at $40.92. Lee covers ...

Best Buy student discounts used to offer aggressive deals on student-friendly tech. However, the program was eliminated and Best Buy student discounts are no longer available. In place of student ...

When you buy through links on our articles, Future and its syndication partners may earn a commission. Cort has expanded its G Series of affordable electric guitars with the G250 SE, an HSS bolt ...

Corcept Shares Rise More Than 45% in Six Months: Here's Why Shares of Corcept Therapeutics Incorporated (NASDAQ: CORT) have gained 46.2% in the past six months against the industry's decline of 2%.